首页> 美国卫生研究院文献>APL Bioengineering >CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays
【2h】

CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays

机译:微孔阵列中抗原感应控制下 3D 乳腺癌球体核心内的 CAR T 细胞浸润和细胞毒性杀伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The success of chimeric antigen receptor (CAR) T cells in blood cancers has intensified efforts to develop CAR T therapies for solid cancers. In the solid tumor microenvironment, CAR T cell trafficking and suppression of cytotoxic killing represent limiting factors for therapeutic efficacy. Here, we present a microwell platform to study CAR T cell interactions with 3D breast tumor spheroids and determine predictors of anti-tumor CAR T cell function. To precisely control antigen sensing, we utilized a switchable adaptor CAR system that covalently attaches to co-administered antibody adaptors and mediates antigen recognition. Following the addition of an anti-HER2 adaptor antibody, primary human CAR T cells exhibited higher infiltration, clustering, and secretion of effector cytokines. By tracking CAR T cell killing in individual spheroids, we showed the suppressive effects of spheroid size and identified the initial CAR T cell to spheroid area ratio as a predictor of cytotoxicity. We demonstrate that larger spheroids exhibit higher hypoxia levels and are infiltrated by CAR T cells with a suppressed activation state, characterized by reduced expression of IFN-γ, TNF-α, and granzyme B. Spatiotemporal analysis revealed lower CAR T cell numbers and cytotoxicity in the spheroid core compared to the periphery. Finally, increasing CAR T cell seeding density resulted in higher CAR T cell infiltration and cancer cell elimination in the spheroid core. Our findings provide new quantitative insight into CAR T cell function within 3D cancer spheroids. Given its miniaturized nature and live imaging capabilities, our microfabricated system holds promise for screening cellular immunotherapies.
机译:嵌合抗原受体 (CAR) T 细胞在血癌中的成功加强了开发实体癌 CAR T 疗法的努力。在实体瘤微环境中,CAR T 细胞运输和细胞毒性杀伤抑制是治疗效果的限制因素。在这里,我们提出了一个微孔平台来研究 CAR T 细胞与 3D 乳腺肿瘤球体的相互作用并确定抗肿瘤 CAR T 细胞功能的预测因子。为了精确控制抗原感应,我们利用了可切换的接头蛋白 CAR 系统,该系统共价连接到共同给药的抗体接头蛋白并介导抗原识别。在添加抗 HER2 衔接蛋白抗体后,原代人 CAR T 细胞表现出更高的浸润、聚集和效应细胞因子分泌。通过跟踪单个球体中的 CAR T 细胞杀伤,我们显示了球体大小的抑制作用,并确定了初始 CAR T 细胞与球体面积的比率作为细胞毒性的预测因子。我们证明,较大的球体表现出较高的缺氧水平,并被活化状态受到抑制的 CAR T 细胞浸润,其特征是 IFN-γ、TNF-α 和颗粒酶 B 的表达降低。时空分析显示,与外周相比,球体核心中的 CAR T 细胞数量和细胞毒性较低。最后,增加 CAR T 细胞接种密度导致球状体核心中更高的 CAR T 细胞浸润和癌细胞消除。我们的研究结果为 3D 癌症球体内的 CAR T 细胞功能提供了新的定量见解。鉴于其小型化特性和实时成像能力,我们的微制造系统有望筛选细胞免疫疗法。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号